Connections NFL Biosciences

ALNFL

FR0014003XT0

Biotechnology & Medical Research

Real-time Euronext Paris 05:00:07 2026-09-10 EDT			5-day change	1st Jan Change
0.8790 ^EUR	-0.57%		+4.00%	-24.96%

07-28	NFL Biosciences Submits Application For Authorization Of The Phase 2 Tonic Clinical Trial Evaluating NFL-102 In Smoking Cessation	CI
07-07	Nfl Biosciences Presents Three Scientific Communications on Nfl-101 and Nfl-102 At 2026 Srnt-Europe Conference	CI

3

Listed companies

0

Private companies

11

Insiders

Relation chart of related listed companies: NFL Biosciences

Active Relations

Past Relations

Related listed companies: NFL Biosciences

Active Relations

Past Relations

Connection statistics

Active

Inactive

Listed companies

Private companies

Activities of related companies

Miscellaneous Commercial Services	1
Pharmaceuticals: Major	1
Medical Specialties	1

Countries of related companies

France	2
Australia	1

NFL Biosciences specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents. At the end of 2025, the company has two products in clinical development (NFL-101 and NFL-102) and two products in preclinical development (NFL-201 for the treatment of cannabis addiction and NFL-301 for alcohol addiction).

Employees

Sector

Biotechnology & Medical Research

Calendar

10-22 Earnings release - Q2 2026

More about the company